Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2024-08-12 00:00:00 ET · period of report 2024-08-08 · accession 0001968202-24-000115 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-08-12 | 2024-08-12 | REGN | STAHL NEIL | EVP Research, Development | G - Gift | $0.00 | -900 | 50.1K | -2% | $0 | |
| M | 2024-08-12 | 2024-08-08 | REGN | STAHL NEIL | EVP Research, Development | S - Sale | $1,084.54 | -5,197 | 56.1K | -8% | -$5.64M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-12 | G | D | 900 | $0.00 | 50,099 | D | — | — | |
| 2 | Common | Common Stock | 2024-08-08 | S | D | 300 | $1,086.15 | 50,999 | D | — | — | (F6) Represents volume-weighted average price of sales of 300 shares of Company stock on August 8, 2024 at prices ranging from $1,086.14 to $1,086.16. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 8, 2024 at each separate price. |
| 3 | Common | Common Stock | 2024-08-08 | S | D | 1,708 | $1,085.01 | 51,299 | D | — | — | (F5) Represents volume-weighted average price of sales of 1,708 shares of Company stock on August 8, 2024 at prices ranging from $1,085.00 to $1,085.79. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 8, 2024 at each separate price. |
| 4 | Common | Common Stock | 2024-08-08 | S | D | 1,006 | $1,083.76 | 54,890 | D | — | — | (F3) Represents volume-weighted average price of sales of 1,006 shares of Company stock on August 8, 2024 at prices ranging from $1,083.27 to $1,083.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 8, 2024 at each separate price. |
| 5 | Common | Common Stock | 2024-08-08 | S | D | 1,883 | $1,084.61 | 53,007 | D | — | — | (F4) Represents volume-weighted average price of sales of 1,883 shares of Company stock on August 8, 2024 at prices ranging from $1,084.01 to $1,084.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 8, 2024 at each separate price. |
| 6 | Common | Common Stock | 2024-08-08 | S | D | 200 | $1,082.69 | 55,896 | D | — | — | (F2) Represents volume-weighted average price of sales of 200 shares of Company stock on August 8, 2024 at prices ranging from $1,082.65 to $1,082.74. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 8, 2024 at each separate price. |
| 7 | Common | Common Stock | 2024-08-08 | S | D | 100 | $1,081.83 | 56,096 | D | — | — | (F1) Represents volume-weighted average price of sales of 100 shares of Company stock on August 8, 2024 at prices ranging from $1,081.75 to $1,081.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 8, 2024 at each separate price. |